E. Morava

Type de document

Co-auteur

L.C. Wilson

A.O. Wilkie

D. Wieczorek

E.M. Wade

I. Veenstra-Knol

A.J. Sutherland-Smith

A. Superti-Furga

T.M. Strom

R.J. Rodenburg

S.P. Robertson

T. Neuhann

T. Morgan

A. McInerney-Leo

D.M. Markie

P. Leo

D. Krakow

C.A. Kim

D. Kerr

Z.A. Jenkins

R.C. Hennekam

E. Fletcher

R. Ferriero

E.L. Duncan

H.C. Duba

P.B. Daniel

T.J. Cho

E. Carter

N. Brunetti-Pierri

M.A. Brown

M. Brivet

N.E. Braverman

A. Boutron

L. Bonafé

A. Bohring

D. Bertola

M R Baumgartner

Y. Anikster

L.C. Adès

M.C. Addor

Date

Source

Serveur académique Lausannois (2)

Mot-clé

protéine (2) thérapie (1) spectacle (1) mutation (1) carte (1) gène (1) enzyme (1) effet (1) dégradation (1) procès (1) Defects (1) Treatment (1) Methods (1) Phenotype (1) Genes (1) Western immunoblotting (1) Dysplasia (1) Therapeutics (1) Skull (1) Scarcity (1) Proteins (1) Protein binding (1) Proportion (1) Phosphorylation (1) Patients (1) Human beings (1) Inhibition (1) Growth (1) Forecasting (1) Fibroblasts (1)

Documents écrit par E. Morava (2) | parle de E. Morava (0)

Mutations in MAP3K7 that Alter the Activity of the TAK1 Signaling Complex Cause Frontometaphyseal Dysplasia.

E.M. Wade et al. (4 août 2016)

Phenylbutyrate increases pyruvate dehydrogenase complex activity in cells harboring a variety of defects

R. Ferriero et al. (2014)